Jesse Boumelha
6PUBLICATIONS
91CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 05, 2024
Hematopoietic aging promotes cancer by fueling IL-1⍺-driven emergency myelopoiesis.Matthew D Park, Jessica Le Berichel, Pauline Hamon
|Apr 18, 2024
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer.Jesse Boumelha, Andrea de Castro, Nourdine Bah
|Dec 04, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.Deborah R Caswell, Philippe Gui, Manasi K Mayekar
|Aug 15, 2023
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy.Jesse Boumelha, Miriam Molina-Arcas, Julian Downward
|Aug 05, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.Jesse Boumelha, Sophie de Carné Trécesson, Emily K Law
|Jul 20, 2022
Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers.Edurne Mugarza, Febe van Maldegem, Jesse Boumelha
Pageof 1
Frequent Collaborators
6 joint publications
Julian Downward
4 joint publications
Miriam Molina-Arcas
3 joint publications
Christopher Moore
3 joint publications
Philip East
2 joint publications
Edurne Mugarza
2 joint publications
William L Brown
2 joint publications
Deborah R Caswell
2 joint publications
Pablo Romero-Clavijo
2 joint publications
Emily K Law
2 joint publications
Sophie de Carné Trécesson
